# Ne oldu?

Ana Salazar Modela Tu Cuerpo Inc. voluntarily recalled Lipofit Extreme Fat Burner 2.0 after the FDA’s laboratory analysis identified undeclared active ingredients in the two tablet formulations. The daytime (AM) tablets were found to contain fluoxetine, a prescription antidepressant, while the nighttime (PM) tablets contained 2,4‑dinitrophenol (DNP), a chemical that is not approved for any human use.

# Ayrıntılar

The FDA’s testing program, which routinely screens dietary supplements for adulterants, detected fluoxetine in the AM tablets at levels that were not disclosed on the product label. Fluoxetine is an FDA‑approved drug for conditions such as depression, bulimia and obsessive‑compulsive disorder, but it is only available by prescription and must be used under medical supervision. The same analysis revealed that the PM tablets contained DNP, a substance that is classified as a toxic pesticide, dye, wood preservative and herbicide. DNP has been marketed illegally as a weight‑loss agent despite a well‑documented record of severe adverse effects.

Because both substances are prohibited in dietary supplements, the company issued a nationwide voluntary recall. The FDA’s recall notice instructs retailers to remove the product from shelves and advises consumers to stop using the supplement immediately and to dispose of any remaining tablets in accordance with local hazardous‑waste guidelines.

# Neden önemli?

Undeclared pharmaceuticals and toxic chemicals in over‑the‑counter products create a direct threat to public health. Fluoxetine can trigger serotonin syndrome, a potentially life‑threatening condition characterized by agitation, rapid heart rate, high blood pressure, and fever, especially when combined with other serotonergic agents. DNP interferes with cellular energy production, leading to uncontrolled hyperthermia, rapid heart rate, liver injury and, in extreme cases, death. The presence of these agents in a weight‑loss supplement bypasses the safety checks that protect patients who take prescription medicines under a doctor’s supervision.

The recall also underscores broader regulatory challenges. The dietary supplement market is less tightly regulated than pharmaceuticals, allowing some manufacturers to add undeclared ingredients to enhance perceived efficacy. When such practices are uncovered, the FDA must act quickly to protect consumers, but the incident highlights the need for continued vigilance and stronger enforcement.

# Sırada ne var?

The FDA will continue to monitor reports of adverse events linked to Lipofit Extreme Fat Burner 2.0 through its MedWatch program. Healthcare professionals are encouraged to report any suspected illnesses or injuries associated with the product. Consumers who have purchased the supplement should check the packaging for the recall notice, cease use, and follow local disposal instructions. The agency also advises the public to verify that any dietary supplement they consider using is manufactured by a reputable company and bears a clear, accurate label.